Home All Products Retatrutide 10 Mg

Retatrutide 10 Mg

$160

Retatrutide 10 mg is an advanced synthetic peptide developed for metabolic and endocrine research applications. It is a next-generation, multi-receptor agonist designed to act on GLP-1, GIP, and glucagon receptors, offering a comprehensive approach tRead More



Product Specifications
  • Brand:

    Retatrutide

  • Dosage Strength:

    10 Mg

  • Drug Class:

    Triple Hormone Receptor Agonist

  • Target Receptors:

    GLP-1, GIP, Glucagon

Description

Product Description

Retatrutide 10 mg is an advanced synthetic peptide developed for metabolic and endocrine research applications. It is a next-generation, multi-receptor agonist designed to act on GLP-1, GIP, and glucagon receptors, offering a comprehensive approach to metabolic pathway modulation. The peptide is supplied in a high-purity, lyophilized (freeze-dried) form to ensure stability, consistency, and extended shelf life. This compound is widely referenced in scientific and investigational settings for studies related to metabolic regulation and energy balance. Retatrutide’s standardized formulation and defined potency make it suitable for controlled laboratory and professional research use.


Key Features



  • Synthetic multi-receptor agonist peptide

  • Strength: 10 mg per vial

  • Targets GLP-1, GIP, and glucagon receptors

  • Lyophilized powder for enhanced stability

  • Intended for laboratory and research applications

Product Specifications
Brand Retatrutide
Dosage Strength 10 mg
Drug Class Triple hormone receptor agonist
Target Receptors GLP-1, GIP, Glucagon
Molecular Type Synthetic peptide
Primary Function Weight management
Mechanism Enhances metabolism & insulin sensitivity
Administration Subcutaneous injection
Purity ≥ 98%
Appearance Lyophilized powder
Solubility Water soluble
Storage Condition Cool & Dry place
Shelf Life 24 months
Packaging Sterile vial
Molecular Category Peptide therapeutic
Stability Temperature sensitive
Application Metabolic research
Target System Endocrine system
Development Stage Clinical research
Country Of Origin Canada
Product Specifications
Brand Retatrutide
Dosage Strength 10 mg
Drug Class Triple hormone receptor agonist
Target Receptors GLP-1, GIP, Glucagon
Molecular Type Synthetic peptide
Primary Function Weight management
Mechanism Enhances metabolism & insulin sensitivity
Administration Subcutaneous injection
Purity ≥ 98%
Appearance Lyophilized powder
Solubility Water soluble
Storage Condition Cool & Dry place
Shelf Life 24 months
Packaging Sterile vial
Molecular Category Peptide therapeutic
Stability Temperature sensitive
Application Metabolic research
Target System Endocrine system
Development Stage Clinical research
Country Of Origin Canada
Home
All Products
Search
Contact